Kyongbo Pharmaceutical Co Ltd Tangible Net Worth Ratio
Kyongbo Pharmaceutical Co Ltd tangible net worth ratio. Kyongbo Pharmaceutical Co Ltd (214390) has a Tangible Net Worth Ratio of 96.6% as of June 2026. This metric is calculated by deducting intangible assets (₩4.98 Billion) from net assets (₩146.99 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 214390 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Kyongbo Pharmaceutical Co Ltd (2014–2025)
Tangible net worth ratio of Kyongbo Pharmaceutical Co Ltd from 2014 to 2025. This chart shows how Kyongbo Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 96.6%, reflecting net assets of ₩146.99 Billion with intangible assets of ₩4.98 Billion KRW. See 214390 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Kyongbo Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2014–2025)
Kyongbo Pharmaceutical Co Ltd tangible net worth ratio by year from 2014 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Kyongbo Pharmaceutical Co Ltd from 2014 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 214390 market cap overview.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.3% | ₩145.74 Billion | ₩3.88 Billion | ₩319.54 Billion | ▲ +0.1 pp |
| 2024 | 97.3% | ₩146.15 Billion | ₩4.01 Billion | ₩283.89 Billion | ▼ -0.2 pp |
| 2023 | 97.5% | ₩144.38 Billion | ₩3.64 Billion | ₩266.31 Billion | ▼ -0.3 pp |
| 2022 | 97.8% | ₩143.70 Billion | ₩3.22 Billion | ₩240.54 Billion | ▲ +0.1 pp |
| 2021 | 97.7% | ₩145.70 Billion | ₩3.35 Billion | ₩236.98 Billion | ▼ -0.3 pp |
| 2020 | 98.0% | ₩156.06 Billion | ₩3.09 Billion | ₩253.24 Billion | ▲ +0.4 pp |
| 2019 | 97.7% | ₩149.16 Billion | ₩3.48 Billion | ₩237.82 Billion | ▼ -0.7 pp |
| 2018 | 98.3% | ₩149.01 Billion | ₩2.50 Billion | ₩221.62 Billion | ▲ +0.1 pp |
| 2017 | 98.2% | ₩141.51 Billion | ₩2.58 Billion | ₩204.87 Billion | ▲ +0.8 pp |
| 2016 | 97.4% | ₩129.40 Billion | ₩3.35 Billion | ₩203.74 Billion | ▼ -1.3 pp |
| 2015 | 98.7% | ₩122.82 Billion | ₩1.64 Billion | ₩195.49 Billion | ▲ +1.7 pp |
| 2014 | 97.0% | ₩68.33 Billion | ₩2.07 Billion | ₩168.03 Billion | — |